French Auto Components Stock News

The market for Capgemini SE's ( EPA:CAP ) shares didn't move much after it posted weak earnings recently. We think that...

One of the biggest stories of last week was how STIF Société anonyme ( EPA:ALSTI ) shares plunged 26% in the week since...

As the European markets navigate through uncertainties spurred by geopolitical tensions and energy price fluctuations, investor sentiment remains cautious yet discerning. In such a climate, growth companies with high insider ownership often stand out as potentially resilient investments due to the alignment of interests between insiders and shareholders, which can be particularly advantageous during periods of economic volatility.

The European markets have been navigating a landscape marked by geopolitical tensions and fluctuating energy prices, with the pan-European STOXX Europe 600 Index showing modest gains. Amidst this backdrop, investors are increasingly looking at diverse investment avenues to capitalize on potential opportunities. Penny stocks, often representing smaller or newer companies, remain an intriguing area for those seeking growth at lower price points. Although the term might seem outdated, these...

Today is shaping up negative for 2CRSI S.A. ( EPA:AL2SI ) shareholders, with the analysts delivering a substantial...

As you might know, Cegedim SA ( EPA:ALCGM ) last week released its latest full-year, and things did not turn out so...

Bolloré (ENXTPA:BOL) has drawn fresh attention after its board proposed an exceptional €1.5 per share dividend, about €4.2b, alongside 2025 results and a regular €0.08 per share dividend plan. See our latest analysis for Bolloré. The exceptional dividend proposal and 2025 earnings release have arrived after a mixed period, with a 3.96% three month share price return, a 1.17% year to date share price gain, but a 1 year total shareholder return decline of 11.46%, suggesting short term momentum...

Recent share performance and current context Pernod Ricard (ENXTPA:RI) has seen its share price move unevenly, with a roughly flat 7 day return, a double digit decline over the past month, and a smaller negative move across the past 3 months. See our latest analysis for Pernod Ricard. The recent 7.9% 1 day share price return to €64.7 comes after a 17.3% 30 day share price decline and sits against a 27.4% 1 year total shareholder return loss, suggesting momentum has been fading over a longer...

Sanofi received FDA Breakthrough Therapy designation for oral venglustat targeting neurological symptoms in type 3 Gaucher disease. Sanofi reported positive phase 3 results for amlitelimab in atopic dermatitis. European regulators issued a positive opinion for Sarclisa subcutaneous with an on body injector for multiple myeloma, potentially introducing dual administration modes in the EU. Sanofi, traded as ENXTPA:SAN, is currently priced at €81.99 and has seen a 5.4% gain over the past week,...

Kering (ENXTPA:KER) has drawn investor attention after recent share price swings, with the stock down over the past month and past 3 months, despite a positive 1 year total return profile. See our latest analysis for Kering. The current share price of €248.3 sits against a 7 day share price return of 6.04%, while the 30 day and year to date share price returns of 13.15% and 18.48% point to fading short term momentum despite a 1 year total shareholder return of 27.89% and weaker 3 and 5 year...

If you are wondering whether ABIVAX Société Anonyme is priced attractively right now, the starting point is to compare what you pay today with what the business could be worth under different valuation lenses. The stock last closed at €89.20, after a 7 day return of an 18.5% decline and a 30 day return of a 13.1% decline, set against a very large 1 year gain and an 11.8x return over 3 years. Recent attention on ABIVAX Société Anonyme has been shaped by ongoing coverage of its position in the...

Ipsen (ENXTPA:IPN) has come into focus after presenting fresh preclinical data at the AACR congress for two first in class oncology candidates, IPN01203 and IPN60300, targeting difficult solid tumor indications. See our latest analysis for Ipsen. The latest oncology data and recent conference activity come at a time when Ipsen’s share price has reached €157.7, with recent momentum reflected in a 90 day share price return of 32.97% and a 1 year total shareholder return of 48.68%. This...

What recent moves in Valeo’s share price tell you Valeo (ENXTPA:FR) has seen mixed share price performance recently, with gains over the past week but weaker moves over the past month and past 3 months, which is prompting closer attention from investors. See our latest analysis for Valeo. At a share price of €10.225, Valeo’s recent 7 day share price return of 4.34% sits against weaker 30 day and year to date share price returns. The 1 year total shareholder return of 20.41% contrasts with...

Thales has partnered with the Dominican Republic to launch the country's first electronic passport, integrating advanced cybersecurity for citizen data. The project establishes a secure e-passport system and ongoing cyber threat monitoring for the Dominican Republic's border and identity infrastructure. For investors tracking ENXTPA:HO, this agreement adds additional real world evidence of Thales' role in digital identity and security, alongside its existing defense and aerospace...

Investors in Innate Pharma S.A. ( EPA:IPH ) had a good week, as its shares rose 2.4% to close at €1.10 following the...

It's been a pretty great week for Netgem SA ( EPA:ALNTG ) shareholders, with its shares surging 11% to €0.76 in the...

Wondering whether EssilorLuxottica Société anonyme is starting to look attractively priced, or if the recent share price leaves little margin for error. The stock last closed at €194.80, with returns of 0.0% over 7 days, a 17.8% decline over 30 days, a 26.6% decline year to date, and a 25.8% decline over 1 year, set against gains of 23.8% over 3 years and 52.1% over 5 years. Recent moves in the share price sit against a backdrop of ongoing interest in the business and its role in the global...

How Accor’s Recent Share Performance Frames Today’s Setup Accor (ENXTPA:AC) has seen its share price fall about 17% over the past month and about 15% over the past 3 months, putting the hotel group’s current valuation and fundamentals back in focus for investors. See our latest analysis for Accor. That recent 17% 1 month share price decline sits against a 1 year total shareholder return of about a 3% decline and a 3 year total shareholder return of about 48%. This suggests shorter term...

Before getting into the numbers, it helps to know why Thales might be on your radar, especially if you are asking whether the current share price still represents value or if most of the opportunity is already reflected in the market. Recently, Thales shares closed at €237.90, with returns of 1.2% year to date, 85.1% over 3 years and 203.1% over 5 years. Over the last 7 days and 30 days the shares showed declines of 1.8% and 6.1% respectively, which can shift how investors think about both...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Valeo (ENXTPA:FR) is investing $225 million in a new manufacturing facility in Texas. The plant will produce central compute units for General Motors' software-defined vehicles. The project supports one of the largest orders in Valeo's history and expands its US footprint. For investors watching the auto technology space, this move places Valeo more firmly among the suppliers building the electronics behind software-defined vehicles. The Texas facility connects directly to Valeo's existing...

Dassault Aviation société anonyme (ENXTPA:AM) has drawn investor attention after recent trading left the shares around €310, with mixed returns, including a decline over the past month and gains over the past 3 months and longer periods. See our latest analysis for Dassault Aviation société anonyme. At a share price of €310, Dassault Aviation société anonyme has recently given back some ground, with a 30 day share price return of a 9.88% decline. This comes even though the 90 day share price...

If you are wondering whether Dassault Systèmes at €16.61 is starting to look like value, you are not alone. This article is designed to help you frame that question clearly. The stock has seen a 3.5% decline over the last 7 days, a 7.9% decline over the last 30 days, a 29.0% decline year to date, and a 53.7% decline over the last year, with a 55.3% decline over 3 years and 54.5% decline over 5 years. These sustained declines have put valuation firmly in focus for many investors, who are...

Sanofi (ENXTPA:SAN) is back in focus after Japan approved Dupixent for adults with moderate to severe bullous pemphigoid, a rare skin disease. This adds another immunology indication to its portfolio. See our latest analysis for Sanofi. News around Dupixent and other rare disease programs has coincided with a short-term lift, with a 1-day share price return of 1.36% and 7-day share price return of 3.84%, although the 1-year total shareholder return of 16.82% and 3-year total shareholder...